Unless you were sleeping under a rock, you are aware of the coordinated attacks on Iran’s nuclear facilities by Israel and the United States.
Phil and Penny Knight made a record-setting $2 billion gift to OHSU Knight Cancer Institute.
Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Visiting professor, Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London; Honorary professor, Institute of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College; Visiting professor, Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
Table of Contents
YOU MAY BE INTERESTED IN
Mary Beckerle, a whitewater kayaker, has advice for all the folks in the cancer field: never catastrophize, never panic.
The Government Accountability Office, an independent, non-partisan congressional watchdog agency, found that NIH violated the Impoundment Control Act of 1974 when it cancelled nearly 2,000 research grants in an effort to comply with several of President Donald Trump’s executive orders, including “Ending Radical And Wasteful Government DEI Programs And Preferencing” (The Cancer Letter, Jan 24, 2025).
EPCORE FL-1 phase III trial results show that subcutaneous epcoritamab in combination with rituximab and lenalidomide reduced the risk of disease progression or death by 79% for patients with relapsed/refractory follicular lymphoma.
The landscape of cancer care is evolving rapidly, with growing recognition that optimal patient outcomes require a whole-person care approach that goes beyond cytotoxic and targeted therapies.
The Stephenson Global Pancreatic Cancer Research Institute and its partner, City of Hope, announced the six inaugural recipients of the Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection, and treatment of pancreatic cancer (The Cancer Letter, Sept. 17, 2024).
